[Skip to Content]
[Skip to Content Landing]
Views 146
Citations 0
Comment & Response
December 26, 2018

Fluoroquinolone Use and Concern About the Cerebral Vasculature

Author Affiliations
  • 1NCH Physician Group, Center for Healthy Living, Naples, Florida
  • 2Comando Brigata Alpina “Julia”/Multinational Land Force, Medical Service, Udine, Italy
JAMA Surg. 2019;154(3):270. doi:10.1001/jamasurg.2018.4297

To the Editor The interesting article by LeMaire et al1 further elucidates the biologic mechanisms by which the use of fluoroquinolones, a widely prescribed class of antibiotics, increases the risk of aortic dissection and aortic aneurysm more than 2-fold.2 In a mouse model of sporadic aortic aneurysm and dissection, mice randomized to the fluoroquinolone ciprofloxacin and also challenged with a high-fat diet and angiotensin II infusion exhibited a significant increase in aortic dissection and rupture.1 Pathologically, these mice demonstrated increased aortic elastic fiber fragmentation and cellular injury in conjunction with a significant decrease in the enzyme lysyl oxidase (LOX) within the aortic media. Lysyl oxidase is operative in the stability and assembly of collagen and elastic fibers in the extracellular matrix (EM).1 Additionally, the mice had increased aortic wall matrix metalloproteinase (MMP) concentration and activity, which is destructive to the EM.1 Therefore, if fluoroquinolone exposure is potentially detrimental to aortic vasculature, resulting in aortic aneurysm and dissection, might it also be harmful to the cerebral vasculature?

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×